The Impact of US Abortion Policy on Rheumatology Clinical Practice: A Cross-Sectional Survey of Rheumatologists

Authors

Bonnie L. Bermas, University of Texas Southwestern Medical Center at DallasFollow
Irene Blanco, Northwestern University Feinberg School of MedicineFollow
Rosalind Ramsey-Goldman, Northwestern University Feinberg School of MedicineFollow
Ashira D. Blazer, Weill Cornell Medicine, Hospital for Special SurgeryFollow
Megan E.B. Clowse, Duke University School of MedicineFollow
Cuoghi Edens, University of Chicago MedicineFollow
Greer Donley, University of Pittsburgh School of LawFollow
Leslie Pierce, University of Pittsburgh School of MedicineFollow
Catherine Wright, University of Pittsburgh School of MedicineFollow
Mehret Birru Talabi, University of Pittsburgh School of MedicineFollow

Document Type

Article

Publication Date

9-14-2023

Abstract

In June of 2022, the US Supreme Court's decision in Dobbs v Jackson Women’s Health overturned Roe v Wade, finding that there was no federal constitutional right to abortion. Subsequently, almost one third of states have near-total abortion bans in effect. Our team distributed a confidential web-based survey to a sample of US-based rheumatologists to assess how the Dobbs decision is affecting the clinical care of reproductive-age females with rheumatic diseases (RMDs), including teratogen prescribing, pregnancy termination referrals, and rheumatologists’ perceived vulnerability to criminalization.

Recommended Citation

Bonnie L. Bermas, Irene Blanco, Rosalind Ramsey-Goldman, Ashira D. Blazer, Megan E. Clowse, Cuoghi Edens, Greer Donley, Leslie Pierce, Catherine Wright & Mehret B. Talabi, The Impact of US Abortion Policy on Rheumatology Clinical Practice: A Cross-Sectional Survey of Rheumatologists, Arthritis & Rheumatology , Letters to the Editor (Online) (2023).
Available at: https://scholarship.law.pitt.edu/fac_articles/581

DOI Link

https://doi.org/10.1002/art.42699